Oncology

Browse Perspectives by Categories in Oncology
Advertisement

Oncology Conference Reporter

Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
conference reporter
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP, FASCO
Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Melinda L. Telli, MD, FASCO
Managing Endocrine Therapy–Related Side Effects and Adherence in HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Virginia Kaklamani, MD, DSc; Ian Krop, MD, PhD; Melinda L. Telli, MD, FASCO
Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2026
conference reporter